Editors for Epidemiology and Global Health
Senior editors
-
Miles P Davenport
University of New South Wales, Australia
Miles Davenport is Professor of Medicine and Head of the Infection Analytics Program at the Kirby Institute for Infection and Immunity at UNSW Sydney. He graduated in medicine from the University of Sydney and completed his DPhil at the University of Oxford in immunology before retraining in mathematical biology. He leads a team of applied mathematicians who use statistical analysis and modelling to understand host-pathogen interactions in infection and immunity. This involves collaboration with a wide variety of experimental and clinical scientists both in Australian and internationally. Major areas of investigation include understanding HIV latency, malaria immunity and treatment, and neonatal immune development. He is a past-President of the Australasian Society for Immunology and is supported by an NHMRC (Australia) Investigator grant.
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Medicine
- Research focus
- virology
- immunity
- vaccines
- HIV/AIDS
- mathematical modelling
- host-pathogen interactions
- biostatistics
- Competing interests statement
- Miles Davenport receives funding from the National Health and Medical Research Council (Australia), the Australian Research Council, and the National Institutes of Health (USA). He is an Associate Editor at PLoS Computational Biology and on the Editorial Board of Immunology and Cell Biology.
-
Eduardo Franco
McGill University, Canada
Eduardo Franco is Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal. He holds BSc (1975) and Licentiate (1976) degrees in biology from Universidade de Campinas, Brazil, and master's (MPH) and doctoral (DrPH) degrees in public health microbiology from the University of North Carolina at Chapel Hill (1981-84). He was a Guest Researcher at the US Centers for Disease Control in Atlanta (1980-81 and 1983-84), and a post-doctoral fellow in cancer epidemiology during 1984 at the International Agency for Research on Cancer in Lyon, France, at the US National Cancer Institute (NCI) in Bethesda, and at Louisiana State University, in New Orleans. Since 1985, he has conducted epidemiologic research on the causes of cancer and on the means to prevent it or to improve patient survival. He is mostly known for his contributions to our understanding of human papillomavirus infection as the cause of cervical cancer and using this knowledge to prevent this cancer via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, the University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He has mentored 115 graduate students and post-doctoral fellows, and 30 undergraduate trainees. He is Officer of the Order of Canada and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Heholds an honorary doctorate from Universidade Fernando Pessoa, Porto, Portugal.
- Expertise
- Cancer Biology
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- cancer prevention
- human papillomavirus
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Entire research program funded by the Medical Research Council of Canada (until 1999), Canadian Institutes of Health Research (CIHR) (1999-present), National Institutes of Health, Canadian Cancer Society, and Cancer Research Society. He has received salary awards from the Fonds de Recherche Quebec Santé and CIHR. He holds a James McGill Professorship and the Minda de Gunzburg Endowed Chair at McGill University. He serves as Editor-in-Chief for Preventive Medicine and Preventive Medicine Reports and serves on the editorial boards of Cancer Epidemiology, Biomarkers & Prevention, International Journal of Cancer, Papillomavirus Research, and Salud Publica de Mexico. He has served as occasional consultant to companies involved with HPV vaccination (Merck and GSK) and HPV diagnostics (Roche, Abbott, Qiagen, and BD).
-
Diane M Harper
University of Michigan, United States
Diane M Harper, MD, MPH, MS, completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Cambridge, Massachusetts, in the fields of Chemical Engineering and Polymerics. She received her medical and public health degrees from the University of Kansas in Kansas City, where she also did residencies in Gynecology/Obstetrics and Family Medicine. Dr Harper has spent the majority of her professional career at Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, as clinician, teacher and researcher in the Departments of Obstetrics and Gynecology, Community and Family Medicine and Women’s and Gender Studies, including improving life for LGBTQ.
She has received the Society of Teachers of Family Medicine (STFM) Excellence in Education Award and the Curtis Hames Research Award honoring her for changing medical care for women through evidence based research. She served as the Chair of Family and Geriatric Medicine at the University of Louisville during which time she also served on the United States Preventive Services Task Force.
She currently is a tenured Professor at the University of Michigan, serving as the Director for Research Management within the Michigan Institute of Clinical and Health Research, one of 50 Clinical and Translational Science Award Research Hubs across the United States. To date she has over 250 peer reviewed publications with over 27,000 citations, and over 40,000 downloads of her seminal review of HPV vaccines.
While at Dartmouth she developed and directed the Gynecologic Cancer Prevention Research Group based at the Norris Cotton Cancer Center in which research on all aspects of HPV associated diseases, specifically cervical cancer prevention was conducted. She is an internationally recognized expert on Human Papillomavirus, the cause of cervical cancer, and its prophylactic and therapeutic vaccines. She has published the sentinel clinical research on HPV vaccines and lectured internationally in over 100 countries. She has served on NCI research committees, European research study sections, addressed the Council on Foreign Affairs, and served as a technical advisor to the World Health Organization. Dr Harper has been honored as one of the top clinicians in her field in the US, and Family Physician of the Year in New Hampshire in 2006.
- Expertise
- Medicine
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- HPV associated diseases
- primary care
- women's health
- cancer precursor detection
- health behaviours
- epidemiology
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Diane Harper has received funding from NCI, NCATS, NHLBI, CDC, multiple national philanthropic organizations, including the American Cancer Society, The Robert Wood Johnson Foundation, and the Susan G Komen Foundation, in addition to state and local funding agencies and collaborations with industry. She serves in editorship capacities on boards including the Annals of Family Medicine, Preventive Medicine Reports, PLoS ONE, and Gynecologic Oncology. She is a peer reviewer for The Lancet, The New England Journal of Medicine, JAMA, among other journals.
Reviewing editors
-
Christine Clayton
Zentrum fuer Molekulare Biologie der Universitaet Heidelberg (ZMBH), Germany
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Research focus
- trypanosomes
- mRNA degradation
- RNA-binding proteins
-
Caroline Colijn
Simon Fraser University, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- evolution of pathogens
- pathogen ecology
- mathematics
- epidemiological modelling
-
Alex R Cook
National University of Singapore, Singapore
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- infectious disease epidemiology
- mathematical modelling
- biostatistics
- health policy
-
Ben Cooper
Mahidol Oxford Tropical Medicine Research Unit, Thailand
- Expertise
- Computational and Systems Biology
- Epidemiology and Global Health
- Research focus
- population biology of communicable diseases
- antimicrobial resistance
- epidemiological methods
-
Jennifer Flegg
University of Melbourne, Australia
- Expertise
- Computational and Systems Biology
- Epidemiology and Global Health
- Research focus
- mathematical modelling
- mathematical biology
- computational biology
- infectious disease dynamics
-
Christine M Friedenreich
University of Calgary, Canada
- Expertise
- Epidemiology and Global Health
- Research focus
- cancer epidemiology
- physical activity
- obesity
- biomarkers
- case-control and cohort studies
- randomized controlled intervention trials
- Experimental organism
- human
-
Sara Hägg
Karolinska Institutet, Sweden
- Expertise
- Epidemiology and Global Health
- Genetics and Genomics
- Research focus
- aging
- gerontology
- biomarkers of aging
- biological age
- molecular epidemiology
- Experimental organism
- human
-
Niel Hens
University of Antwerp, Belgium
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- multivariate statistics
- HCV and HIV coinfection
- infectious disease modelling
- applied statistics
-
Edward D Janus
University of Melbourne, Australia
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cardiovascular disease
- diabetes
- prevention
- chronic diseases
- clinical guidelines
-
Prabhat Jha
Saint Michael's Hospital, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- global health
- infectious disease and population dynamics
- randomized controlled trials
-
Mark Jit
London School of Hygiene & Tropical Medicine, and Public Health England, United Kingdom
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- vaccines
- infectious disease epidemiology
- mathematical modelling
- health economics
- low- and middle-income countries
- Experimental organism
- human
- vaccine-preventable pathogens
- human papillomavirus
- measles virus
- rotavirus
- influenza virus
- S. pneumoniae
-
Urszula Krzych
Walter Reed Army Institute of Research, United States
- Expertise
- Epidemiology and Global Health
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- adoptive immunity
- immune memory responses
- liver resident T memory cells
- Plasmodium liver stage infection
- Plasmodium antigens/vaccines
- design of malaria vaccines
-
Joseph Lewnard
University of California, Berkeley , United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- epidemiology
- infectious disease
- vaccines
- casual inference
- transmission modelling
- streptococcus spp.
- respiratory pathogens
- enteric disease
-
Marc Lipsitch
Harvard T.H. Chan School of Public Health, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- pathogen transmission modeling
- evolution of pathogens
- vaccine epidemiology
- antimicrobial resistance
- research ethics
- Experimental organism
- S. pneumoniae
-
Ruth Loos
The Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Epidemiology and Global Health
- Medicine
- Genetics and Genomics
- Research focus
- genetic epidemiology
- obesity
- prediction
- gene discovery
- precision medicine
- Experimental organism
- human
-
Talía Malagón
McGill University, Canada
- Expertise
- Epidemiology and Global Health
- Research focus
- human papillomavirus
- cervical cancer
- screening
- vaccination
- mathematical modelling
- cancer epidemiology
- sexually transmitted infections
-
Belinda Nicolau
McGill University, Canada
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- social determinants of health
-
C. Brandon Ogbunugafor
Yale University, United States
- Expertise
- Computational and Systems Biology
- Evolutionary Biology
- Epidemiology and Global Health
- Physics of Living Systems
- Microbiology and Infectious Disease
- Research focus
- disease ecology
- microbial evolution
- population genetics
- epidemiology
- evolutionary medicine
- Experimental organism
- E. coli
- human
- P. falciparum
- S. cerevisiae
- viruses
-
Isabel Rodriguez-Barraquer
University of California, San Francisco, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- dengue
- malaria
- Zika
- vector-bone diseases
- serology
- modeling
- Experimental organism
- human
-
Joshua T Schiffer
Fred Hutchinson Cancer Research Center, United States
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Immunology and Inflammation
- Medicine
- Research focus
- HSV-2
- herpesviruses
- mucosa
- T cells
- viral shedding
- mathematical modelling
- Experimental organism
- human
- viruses
-
Viviana Simon
The Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- viral-host interactions
- retroviral restriction factors
- HIV drug resistance
-
Margaret Stanley
University of Cambridge, United Kingdom
- Expertise
- Cancer Biology
- Microbiology and Infectious Disease
- Medicine
- Epidemiology and Global Health
- Research focus
- vaccines
- cervix cancer
- cervix precancer
- keratinocyte biology
- human papillomavirus
- DNA viruses
- vaccine immunology
- Experimental organism
- human
-
M Dawn Teare
Newcastle University, United Kingdom
- Expertise
- Computational and Systems Biology
- Epidemiology and Global Health
- Medicine
- Research focus
- statistics
- population genetics
- epidemiology
-
Jacco Wallinga
National Institute for Public Health and the Environment, Netherlands
Leiden University Medical Center, Netherlands- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Medicine
- Research focus
- modeling of infectious diseases
- vaccination
- infectious disease control
- public health
- bioinformatics
-
Amy Wesolowski
Johns Hopkins Bloomberg School of Public Health, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- infectious diseases
- mobility
- malaria
- parasites
- measles